Home
  • Our Company
    • Biopharmaceutical Acceleration Model®
    • Dynamic Assembly®
    • Kinetic™
    • Syneos One®
    • The Trusted Process®
    • Our Leadership
    • Our Vision, Mission and Values
    • Resource Library
    • Events
    • Awards
    • Site Relationships
    • Our Office Locations
  • Solutions
    • Clinical Development
      • Full Service
        • Decentralized Solutions
        • Bioanalytical Solutions
        • Early Phase
        • Phase II - III
        • Phase IIIb - IV
        • Real World and Late Phase
        • Medical Device and Diagnostics
      • FSP 360
        • Biostatistics and Statistical Programming
        • Clinical Data Management
        • Clinical Development Services Project Management
        • Clinical Monitoring
        • Drug Safety and Pharmacovigilance
        • Investigator Management Solutions
        • Medical Writing and Communications
        • Rater Training
        • Site Start Up
        • Site and Patient Access
        • Trial Master File Operations
    • Medical Affairs
    • Commercialization
      • Advertising
      • AnswerSuite
      • Behavioral Insights
      • Brand Naming and Development
      • Clinical Field Teams
      • Commercial Recruiting Solutions
      • Communications
      • Deployment Solutions
      • Digital and Social Media
      • Full-Service Commercial
      • Medical Communications
      • Policy and Advocacy
      • Public Relations
      • Reputation and Risk Management
      • Selling Solutions
      • Training and Learning Solutions
      • Value and Access
    • Consulting
      • Commercial Advisory Group
        • Portfolio Strategy and Transactions
        • Health Economics and Outcomes Research
        • Product and Franchise Strategy
        • Value and Access
        • Customer and Digital Engagement
      • Scientific and Medical Affairs Advisory Group
        • Quality and Compliance
        • Regulatory
      • Risk and Program Management Advisory Group
        • REMS and Risk Management (PMO)
      • R&D Advisory Group
        • Research and Development
    • Syneos One®
  • Therapeutic Expertise
    • Therapeutic Areas
      • Cardiovascular
      • Central Nervous System
        • CNS Analgesia
        • CNS Clinical Surveillance Team
        • CNS Neurology
        • CNS Psychiatry
      • Endocrine and Metabolic
      • Gastroenterology
      • Immunology and Inflammation
      • Infectious Disease and Vaccines
      • Ophthalmology
      • Respiratory
      • Women's Health
      • Oncology and Hematology
        • Targeted Therapies
        • Novel and Emerging Therapies
        • Immuno-Oncology
    • Cross-Functional Solutions
      • Biosimilars
      • Cell and Gene Therapy
      • Patient Voice
      • Pediatrics
      • Rare Diseases
    • Our Experience Hub
  • Insights Hub
  • Careers
  • インサイト ハブ
  • 中途採用
  • 新卒採用 (日本)
  • News
    • In The News
    • Press Releases
    • Press Kit
  • Investors
  • Investigators
  • Transparency
  • Suppliers
    • Supplier Code of Conduct
    • Standard Contractual Clauses for Suppliers
    • Supplier Diversity and Inclusion
    • Supplier Terms and Conditions
  • Contact
  • English
  • Français Canadien
  • 日本語

Search form

Home Insights Hub The 2021 Health Trends Series COVID-19’s Lasting Impact
Trends

COVID-19’s Lasting Impact

April 15, 2021
Content 

Fighting an intense and immediate enemy like a novel coronavirus necessarily interrupts healthcare. Resources are diverted, experts are redeployed, people shelter at home. We battle the disease and put normal healthcare on hold. Experts and advocates are looking ahead to what that means in the next months and years. Chronic conditions treatment didn’t advance. Cancers and heart disease went underdiagnosed. People lived with high levels of stress and anxiety, often putting healthy routines on pause, too. Loss of work added new financial and personal pressures. As we enter a new year of promise for a vaccine, we look at all the things a vaccine just can’t solve for.

Image or Video 

2021 Health Trends - COVID-19s Lasting Impact.png

2021 Health Trends - COVID-19s Lasting Impact
Critical Questions

How can we help doctors and patients reconnect and fast-track needed tests and advances in care?

What RWE and RWD should we be looking at for clues into what’s next?

Did you know...

Columns 
Content 
Image or Video 

46 percent - COVID-19s Lasting Impact.png

46 percent - COVID-19s Lasting Impact

46%: Early in the pandemic, the mean number of weekly new diagnoses for six common cancers dropped by 46%. A study of data at twenty key institutions, found that compared to the same time period last year, breast cancer screenings are down 89%; colorectal, 85%.

— JAMA Network, Quest Diagnostics, 2020;
JCO Clinical Cancer Informatics, 2020

Content 
Image or Video 

55 Percent - COVID-19s Lasting Impact.png

55 Percent - COVID-19s Lasting Impact

55%: Stress and boredom are driving an increase in alcohol and drug use during the pandemic. In one recent study, 55% of respondents reported higher rates of alcohol consumption; 18%, a significant increase. In the states hardest hit (NY, NJ, MA, RI, CT), 67% reported an increase; 25%, a significant one.

— Baptist Health, 2020

 

Download a PDF of this Content Below

The 2021 Health Trends Series
A New Era of Home Diagnosis
Forming the Future Field
Enabled 
Download
Previous

Fill out the form below to download your requested Insights Hub Article.

*Required fields

By submitting this form, you agree to our Terms & Conditions and Privacy Policy of our website. You can withdraw your consent at any time. If you have any questions, please Contact Us.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chapters

Chapter:
19
A New Era of Home Diagnosis
Chapter:
20
COVID-19’s Lasting Impact

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
Branded Logo
Subscribe to Our Newsletter Share

Related Content

The 2021 Health Trends Series
July 1, 2021
A New Era of Home Diagnosis
April 8, 2021
Forming the Future Field
April 1, 2021
Interested in Syneos Health?
Get In Touch
Connect
  • LinkedInLinkedIn
  • TwitterTwitter
  • FacebookFacebook
  • InstagramInstagram

Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. We support a diverse, equitable and inclusive culture. Contact Us

Our Headquarters
Corporate Headquarters
  • 1030 Sync Street
  • Morrisville, NC 27560
  •  
  • Phone: +1 919 876 9300
  • Fax: +1 919 876 9360
  • Toll-Free: +1 866 462 7373
Menu
  • Solutions
  • Therapeutic Expertise
  • Brand Directory
  • 労働者派遣法に基づく情報公開
  • Careers
  • Study Participants
  • Media
  • Business Ethics Helpline
  • Events
  • Transparency
© 2022 Syneos Health. All Rights Reserved.
  • Terms Of Use
  • Privacy Notice
  • Privacy Shield
  • Online Tracking Opt-Out